September 01, 2021

Looking Ahead to Factors Shaping Market Activity

A bylined article exploring the factors shaping M&A activity in the life sciences sector by EMEA CRO Merlin Piscitelli was published in the September issue of Pharmaceutical Technology Europe. The article highlights how the sector continues to attract investor interest despite unprecedented disruption caused by the pandemic. 

Contacts

Media Relations
Marta Carraro

Vice President, Communications

212.367.6162

[email protected]

Investor Relations
Jennifer Percy

651.632.4009

[email protected]

You may also like:

2022 M&A Is Mind-Boggling. What’s Fueling All the Activity?

2022 M&A is off to a mind-boggling start. Datasite's 2022 Outlook and 2021 Year in Review survey explains what's top of mind for dealmakers this year.

How the Great Resignation is Affecting the C-Suite

Between July and September 2021, a million Britons changed jobs. Datasite's 2022 M&A Outlook and 2021 Year in Review survey cites a top priority for UK dealmakers this year is family time and reassessing career plans.

Raconteur Logo
Another Hot Year of M&A Expected in 2022

CEO Rusty Wiley shares his insights on what dealmakers can expect in 2022, based on data from our platform and Datasite's 2022 M&A Outlook and 2021 Year in Review.

Nasdaq